HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicola Pozzi Selected Research

Metalloproteases (Metalloproteinases)

3/2012Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicola Pozzi Research Topics

Disease

10Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
12/2023 - 05/2010
7Thrombosis (Thrombus)
12/2023 - 05/2010
5COVID-19
08/2021 - 01/2020
4Hemorrhage
01/2023 - 12/2014
3Neoplasms (Cancer)
09/2023 - 01/2022
3Autoimmune Diseases (Autoimmune Disease)
01/2022 - 05/2010
2Atypical Hemolytic Uremic Syndrome
10/2023 - 07/2019
2Critical Illness (Critically Ill)
04/2022 - 03/2019
2Stroke (Strokes)
12/2018 - 02/2010
2Sepsis (Septicemia)
03/2012 - 02/2010
1Tuberculosis (Tuberculoses)
09/2023
1Macular Degeneration (Age-Related Maculopathy)
10/2022
1Thrombotic Microangiopathies
01/2022
1Infections
01/2022
1Membranous Glomerulonephritis (Membranous Nephropathy)
01/2022
1Inflammation (Inflammations)
08/2021
1Rupture
01/2021
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
01/2020
1Thromboembolism
01/2020
1Vascular System Injuries
01/2020
1Kidney Diseases (Kidney Disease)
11/2017
1Protein C Deficiency
01/2017
1Chronic Kidney Failure (Chronic Renal Failure)
03/2012
1Bacterial Infections (Bacterial Infection)
03/2012
1Autolysis
11/2011
1Coronary Artery Disease (Coronary Atherosclerosis)
02/2010

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
09/2023 - 01/2017
5AntibodiesIBA
01/2021 - 11/2019
4AnticoagulantsIBA
01/2023 - 01/2018
4AutoantibodiesIBA
01/2022 - 05/2010
4ThrombinFDA Link
01/2020 - 11/2011
3Antiphospholipid AntibodiesIBA
12/2023 - 01/2020
3Complement Factor I (C3b Inactivator)IBA
10/2023 - 01/2022
3Complement System Proteins (Complement)IBA
01/2022 - 01/2021
3Immunoglobulin G (IgG)IBA
08/2021 - 11/2019
3Prothrombin (Factor II)IBA
01/2021 - 12/2014
3EpitopesIBA
07/2020 - 11/2019
3Phospholipids (Phosphatides)FDA LinkGeneric
07/2020 - 01/2020
2PhosphatidylserinesIBA
01/2021 - 11/2019
2AntithrombinsIBA
01/2020 - 01/2018
1CalciumIBA
10/2023
1Factor Xa InhibitorsIBA
01/2023
1Oxidoreductases (Dehydrogenase)IBA
01/2023
1oxidized low density lipoproteinIBA
01/2023
1Protein Disulfide-IsomerasesIBA
01/2023
1Oxidants (Oxidizing Agents)IBA
01/2023
1chemotactic factor inactivatorIBA
10/2022
1Phospholipase A2 ReceptorsIBA
01/2022
1Complement Factor B (Factor B)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1APTIBA
01/2021
1PlasticsIBA
01/2021
1DisulfidesIBA
01/2021
1Glycoproteins (Glycoprotein)IBA
01/2020
1SolutionsIBA
01/2020
1FibrinIBA
01/2020
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2020
1AntigensIBA
11/2019
1Fibrinogen (Factor I)FDA Link
07/2019
1meizothrombinIBA
12/2018
1Blood Proteins (Serum Proteins)IBA
11/2017
1Apolipoprotein L1IBA
11/2017
1Protein CIBA
01/2017
1ThrombomodulinIBA
01/2017
1AutoantigensIBA
12/2016
1ZincIBA
03/2012
1Bacterial AdhesinsIBA
03/2012
1DisintegrinsIBA
03/2012
1ThrombospondinsIBA
03/2012
1von Willebrand FactorIBA
03/2012
1Metalloproteases (Metalloproteinases)IBA
03/2012
1Serine Proteases (Serine Protease)IBA
03/2012
1Peptide Hydrolases (Proteases)FDA Link
03/2012
1EnzymesIBA
11/2011
1beta 2-Glycoprotein I (Apolipoprotein H)IBA
05/2010
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2010
1Peroxynitrous Acid (Peroxynitrite)IBA
02/2010

Therapy/Procedure

3Therapeutics
09/2023 - 01/2020
2Critical Care (Surgical Intensive Care)
04/2022 - 03/2019